Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Colgate-Palmolive ( (CL) ) has provided an update.
On July 31, 2025, Colgate-Palmolive‘s Board of Directors approved a new three-year productivity program aimed at supporting its 2030 strategy. This program focuses on optimizing the company’s global supply chain, streamlining organizational structures, and reducing overhead costs, with projected pre-tax charges between $200 and $300 million over three years. The program is expected to enhance the company’s operational efficiency and strategic alignment, with most charges incurred by the end of 2028, potentially impacting stakeholders and market positioning.
The most recent analyst rating on (CL) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on Colgate-Palmolive stock, see the CL Stock Forecast page.
Spark’s Take on CL Stock
According to Spark, TipRanks’ AI Analyst, CL is a Neutral.
Colgate-Palmolive’s strong profitability and strategic initiatives are balanced by risks from high leverage and valuation concerns. The earnings call and recent corporate events provide optimism, but market and macroeconomic challenges pose ongoing risks.
To see Spark’s full report on CL stock, click here.
More about Colgate-Palmolive
Colgate-Palmolive is a leading consumer products company specializing in the production and distribution of oral care, personal care, home care, and pet nutrition products. The company is known for its global market presence and commitment to sustainability and innovation.
Average Trading Volume: 4,911,088
Technical Sentiment Signal: Hold
Current Market Cap: $67.95B
See more insights into CL stock on TipRanks’ Stock Analysis page.